Old Web
English
Sign In
Acemap
>
Paper
>
P18.01 Treatment Efficacy of HER2-Mutant Lung Adenocarcinoma by Immune Checkpoint Inhibitors
P18.01 Treatment Efficacy of HER2-Mutant Lung Adenocarcinoma by Immune Checkpoint Inhibitors
2021
Xiangling Chu
H. Qiang
Mengqing Xie
X. Li
Jianfu Zhao
Yi-Long Wu
Juan Zhou
J. Ye
Chong-Ke Zhao
Chaonan Han
Tianqing Chu
Chunxia Su
Keywords:
Mutant
Medicine
immune checkpoint inhibitors
Cancer research
treatment efficacy
Adenocarcinoma
Lung
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]